Blogger

Vitamin D Supplements May Limit Tenofovir Bone Toxicity

Thanks to Jules Levin for sponsoring this article in his web site Natap.org Vitamin D Supplements May Limit Tenofovir Bone Toxicity 18th Conference on Retroviruses and Opportunistic Infections, February 27-March 2, 2011, Boston Mark Mascolini In a randomized trial of 18-to-25-year-olds, vitamin D3 supplementation appeared to offset a negative impact of tenofovir on parathyroid hormone …

Vitamin D Supplements May Limit Tenofovir Bone Toxicity Read More »

Interview with Man Who Got Cured of HIV

This link has a video of an interview with Tim Brown, the man who got cured of HIV (who I refer to as the “Berlin Patient”  in my article below). https://feedroom.businessweek.com/?fr_story=4a74617791423dc8652dd78d84817c27ba4045aa From TheBodypro.com Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? By Nelson Vergel March 2, 2011 Jay Lalezari, M.D., from …

Interview with Man Who Got Cured of HIV Read More »

March 23 in Fort Lauderdale: Two Experts to Speak about Taboo Health Subjects for Gay Men

FOR IMMEDIATE RELEASE CONTACT: STEVE STAGON, 954-815-2550 Two Experts to Speak about Taboo Health Subjects for Gay Men March 15, 2011- Fort Lauderdale, FL.  Two lectures sponsored by the PALS Project and “Life Goes On” Elton John Foundation will be provided by  top experts who will speak about  anal and erectile health, two topics that …

March 23 in Fort Lauderdale: Two Experts to Speak about Taboo Health Subjects for Gay Men Read More »

How to Improve Finances Despite HIV

FREE WORSKSHOP  Program for Wellness Restoration, the Houston Buyers Club and LIVE Consortium present What to Do Now that You are Living Longer? How to Improve Finances Despite HIV A seminar with author & financial advisor Per Larson  *Limited seating* March 22, 6:30 pm- United Way-50 Waugh Drive-Houston, TX 77007  Register here : https://hivpersonalfinances.eventbrite.com/ Among the …

How to Improve Finances Despite HIV Read More »

Dolutegravir, Trii and new abacavir data- How it all ties together

By Nelson Vergel Powerusa.org Dr Joe Eron presented new dosing and efficacy phase 2b data on the new GSK integrase inhibitor dolutegravir (DTG, S/GSK1349572) using 50 mg twice a day in patients whose HIV virus has developed resistance to raltegravir (Isentress). Prior data presented in Vienna from a cohort (cohort 1) of patients who took …

Dolutegravir, Trii and new abacavir data- How it all ties together Read More »

Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?

Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? By Nelson Vergel March 2, 2011 Jay Lalezari, M.D., from the University of California-San Francisco presented first-of-its-kind study data on the use of zinc finger nucleases (ZFNs) to artificially disrupt the CCR5 receptor on the surface of CD4 cells, which HIV uses to infect its …

Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? Read More »